- 专利标题: Targeting vector-phospholipid conjugates
-
申请号: US14190860申请日: 2014-02-26
-
公开(公告)号: US09295737B2公开(公告)日: 2016-03-29
- 发明人: Philippe Bussat , Samir Cherkaoui , Hong (Helen) Fan , Bernard Lamy , Palaniappa Nanjappan , Radhakrishna K. Pillai , Sibylle Pochon , Bo Song , Rolf E. Swenson
- 申请人: BRACCO SUISSE SA
- 申请人地址: CH Manno
- 专利权人: BRACCO SUISSE SA
- 当前专利权人: BRACCO SUISSE SA
- 当前专利权人地址: CH Manno
- 代理机构: Pearl Cohen Zedek Latzer Baratz LLP
- 主分类号: A61K38/00
- IPC分类号: A61K38/00 ; C07K14/00 ; A61K49/22 ; A61K47/48 ; C07K7/08 ; C07K14/52 ; C07K14/71
摘要:
Peptide vectors having high KDR binding affinity and processes for making such vectors are provided. The peptide vectors may be conjugated to phospholipids and included in ultrasound contrast agent compositions. Such ultrasound contrast agents are particularly useful in therapeutic and diagnostic methods, such as in imaging KDR-containing tissue and in the evaluation and treatment of angiogenic processes associated with neoplastic conditions. The present invention also provides processes for the large scale production of highly pure dimeric and monomeric peptide phospholipid conjugates as well as precursor materials used to form the conjugates. The present invention further provides processes for the large scale production of highly pure peptide phospholipid conjugates which contain very low levels of TFA.
公开/授权文献
- US20140206837A1 TARGETING VECTOR-PHOSPHOLIPID CONJUGATES 公开/授权日:2014-07-24
信息查询
IPC分类: